Literature DB >> 12907251

DNA damage and expression of checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in taurine-deficient cardiomyocytes.

Olga Golubnitschaja1, Heike Moenkemann, Kerstin Kim, Mahmood S Mozaffari.   

Abstract

OBJECTIVE: Taurine depletion is associated with development of cardiomyopathy. Further, oxidative stress is advanced as a critical factor mediating the effect of taurine deficiency on target organs. However, the molecular mechanism(s) linking taurine deficiency with the development of cardiomyopathy remains elusive. Since transition between apoptotic degeneration and cell proliferation in stress conditions is regulated at cell cycle checkpoints, we determined the expression of two such genes, namely p21(WAF1/CIP1) and 14-3-3 sigma as well as p53 that are responsible for oxidative stress and DNA damage. We also carried out quantitative determination of DNA damage.
METHODS: Cardiomyocytes from beta-alanine-induced taurine-depleted (TD) rats were used for this investigation. Single- and double-stranded DNA damage was quantified using comet assay analysis. Western blot and two-dimensional polyacrylamide gel electrophoresis with immunoblotting analysis were applied for protein analysis.
RESULTS: Comet assay analysis indicated that the extent of double-stranded DNA damage was greater in TD than in control cardiomyocytes. Whereas only traces of both p53 and p21(WAF1/CIP1) and no detectable expression of 14-3-3 sigma were found in cardiomyocytes of control animals, the TD cardiomyocytes expressed all three genes.
CONCLUSIONS: DNA damage and the consequent up-regulation of checkpoint proteins observed in TD cardiomyocytes indicate the involvement of cell cycle control mechanisms in the effect of taurine deficiency on cardiomyocytes. Single- and double-stranded DNA damage and the consequent arrest of cell proliferation in both G(1) and G(2) phases of the cell cycle induced by checkpoint proteins may trigger the cardiomyopathy that is associated with taurine deficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907251     DOI: 10.1016/s0006-2952(03)00285-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.

Authors:  Kristina Yeghiazaryan; Hans H Schild; Olga Golubnitschaja
Journal:  Infect Disord Drug Targets       Date:  2012-10

2.  High CpG island methylation of p16 gene and loss of p16 protein expression associate with the development and progression of tetralogy of Fallot.

Authors:  Si-Ju Gao; Gui-Fang Zhang; Rong-Peng Zhang
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

3.  Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines.

Authors:  Kristina Yeghiazaryan; Viktoriya Peeva; Aparna Shenoy; Hans H Schild; Olga Golubnitschaja
Journal:  Infect Disord Drug Targets       Date:  2011-04

4.  Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach.

Authors:  Olga Golubnitschaja; Jiri Polivka; Kristina Yeghiazaryan; Leonard Berliner
Journal:  EPMA J       Date:  2018-08-17       Impact factor: 6.543

5.  Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Vincenzo Costigliola; Daniela Trog; Michael Braun; Manuel Debald; Walther Kuhn; Hans H Schild
Journal:  EPMA J       Date:  2013-02-19       Impact factor: 6.543

Review 6.  14-3-3 protein regulation of excitation-contraction coupling.

Authors:  Walter C Thompson; Paul H Goldspink
Journal:  Pflugers Arch       Date:  2021-11-25       Impact factor: 3.657

7.  Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification.

Authors:  Holger Fröhlich; Sabyasachi Patjoshi; Kristina Yeghiazaryan; Christina Kehrer; Walther Kuhn; Olga Golubnitschaja
Journal:  EPMA J       Date:  2018-04-11       Impact factor: 6.543

8.  Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring 'anecdotes' of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan
Journal:  EPMA J       Date:  2012-10-07       Impact factor: 6.543

9.  Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs.

Authors:  Kristina Yeghiazaryan; Josef Flammer; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

10.  'Suspect molecular signature' in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention.

Authors:  Manuel Debald; Kristina Yeghiazaryan; Melanie Cebioglu; Walther Kuhn; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2013-09-16       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.